![logo](/logos/301130.SZ.webp)
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
SZSE:301130.SZ
28.32 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||
Net Income
| 50.502 | 40.723 | 52.019 | 49.742 | 54.613 | 41.36 | 45.625 | 0 | 0 | 0 | 0 |
Depreciation & Amortization
| 18.596 | 18.488 | 18.714 | 20.458 | 20.671 | 17.939 | 13.512 | 0 | 0 | 0 | 0 |
Deferred Income Tax
| 0.725 | 0.048 | 0.251 | 0.616 | 2.348 | -1.609 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| -3.119 | 17.508 | -7.921 | -0.569 | -5.406 | 1.138 | -24.965 | 0 | 0 | 0 | 0 |
Accounts Receivables
| 11.779 | 2.035 | -1.019 | 0.538 | -8.066 | 4.902 | -15.496 | 0 | 0 | 0 | 0 |
Inventory
| -7.43 | 5.612 | -6.479 | 1.465 | 3.521 | -6.52 | -5.839 | 0 | 0 | 0 | 0 |
Accounts Payables
| -4.385 | -2.035 | 1.019 | -0.538 | 8.066 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| -3.082 | 11.896 | -1.442 | -2.034 | -8.927 | 7.659 | -19.126 | 0 | 0 | 0 | 0 |
Other Non Cash Items
| 33.852 | -9.491 | -3.798 | -5.09 | -3.945 | 5.65 | -2.825 | 0 | 0 | 0 | 0 |
Operating Cash Flow
| 63.327 | 67.228 | 59.014 | 64.542 | 65.933 | 66.087 | 31.348 | 0 | 0 | 0 | 0 |
Investing Activities: | |||||||||||
Investments In Property Plant And Equipment
| -123.173 | -54.399 | -21.184 | -14.512 | -13.243 | -31.086 | -44.207 | -50.678 | -7.828 | -12.093 | -12.399 |
Acquisitions Net
| 2.601 | 0 | 0 | 0 | 13.255 | 31.086 | 44.207 | 5.694 | 7.852 | 0 | 0 |
Purchases Of Investments
| -1,048 | -1,357 | -145 | -16 | -138 | -20 | -29 | -185 | -47 | 0 | 0 |
Sales Maturities Of Investments
| 1,250 | 1,016.989 | 148.122 | 0 | 89.288 | 20.483 | 70.034 | 176.238 | 6 | 0 | 0 |
Other Investing Activites
| 213.543 | 0 | -0 | -14.512 | -13.243 | -31.086 | 0 | 0.009 | 0.024 | -12.093 | 0.03 |
Investing Cash Flow
| 81.428 | -394.409 | -18.062 | -30.512 | -61.943 | -30.603 | -3.172 | -53.738 | -48.805 | -12.093 | -12.369 |
Financing Activities: | |||||||||||
Debt Repayment
| -0.237 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10 | -10 | -15 |
Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| -12.929 | -10.505 | 0 | -24.241 | -18.181 | -12.121 | -10.827 | -16.345 | -8.448 | -18.64 | -29.836 |
Other Financing Activities
| -0.237 | 391.834 | -0.06 | -4.005 | -0.3 | -0.83 | 50.96 | -0.6 | 14.13 | 9.3 | 65.541 |
Financing Cash Flow
| -13.166 | 381.329 | -0.06 | -28.246 | -18.481 | -12.951 | 40.133 | -16.945 | -4.318 | -19.34 | 20.704 |
Other Information: | |||||||||||
Effect Of Forex Changes On Cash
| 0 | -0 | -0 | -0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| 131.591 | 54.148 | 40.892 | 5.784 | -14.491 | 22.534 | 68.308 | -26.953 | -15.389 | 4.976 | 41.588 |
Cash At End Of Period
| 334.37 | 202.221 | 148.073 | 107.181 | 101.397 | 115.888 | 93.354 | 11.698 | 38.651 | 54.04 | 49.064 |